Enhancing the Effects of Alcohol Treatment With Lamotrigine

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

October 24, 2023

Study Completion Date

October 24, 2024

Conditions
Alcohol Use Disorder
Interventions
DRUG

Lamotrigine

Participants will be randomized to lamotrigine (25 mg/day to 200 mg/day in two divided doses) for 9 weeks. A comparator group will receive placebo (sugar pills).

DRUG

Placebo

Matching placebo (sugar pill)

Trial Locations (1)

02903

Brown University Center for Alcohol and Addiction Studies, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

collaborator

Rhode Island Hospital

OTHER

lead

Brown University

OTHER